Stay updated on Canagliflozin Impact on Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Canagliflozin Impact on Heart Failure Clinical Trial page.

Latest updates to the Canagliflozin Impact on Heart Failure Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page history now includes Revision: v3.4.2; prior notices about funding lapse and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check21 days agoChange DetectedAdded a general notice about government funding status. Updated the site revision tag from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check28 days agoChange DetectedShow glossary option added and color-coding legend updated; 'No FEAR Act Data' removed and site revision updated to v3.4.0.SummaryDifference0.8%

- Check42 days agoChange DetectedThe history shows a new revision entry (v3.3.4) replacing the previous v3.3.3. This update is a backend revision to the page and does not modify study details or results.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the record history, and the footer now excludes the 'HHS Vulnerability Disclosure' link as well as the prior 'Revision: v3.3.2' entry.SummaryDifference0.2%

- Check92 days agoChange DetectedPage history shows the addition of Revision: v3.3.2 and the removal of Revision: v3.2.0; no substantive study content appears to be affected.SummaryDifference0.1%

Stay in the know with updates to Canagliflozin Impact on Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Canagliflozin Impact on Heart Failure Clinical Trial page.